Hikma Pharmaceuticals (LSE:HIK) Accounts Payable : £244 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Hikma Pharmaceuticals Accounts Payable?

Hikma Pharmaceuticals's Accounts Payable for the quarter that ended in Dec. 2023 was £244 Mil.

Hikma Pharmaceuticals's quarterly Accounts Payable increased from Dec. 2022 (£239 Mil) to Jun. 2023 (£400 Mil) but then declined from Jun. 2023 (£400 Mil) to Dec. 2023 (£244 Mil).

Hikma Pharmaceuticals's annual Accounts Payable increased from Dec. 2021 (£197 Mil) to Dec. 2022 (£239 Mil) and increased from Dec. 2022 (£239 Mil) to Dec. 2023 (£244 Mil).

Hikma Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Hikma Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Accounts Payable Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

218.22

207.58

197.02

238.91

244.11

Hikma Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															197.02	207.06	238.91	399.96	244.11

Hikma Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Hikma Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikma Pharmaceuticals (LSE:HIK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (LSE:HIK) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HKMPF:USA HIKl:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Hikma Pharmaceuticals (LSE:HIK) Headlines

No Headlines